top of page

Molecular Therapy Presents: Immunotherapy for Autoimmune Diseases

Join us on Wednesday, March 19 at 10 a.m. CST for the next installment of ASGCT's Molecular Therapy Presents webinar series: Immunotherapy in Autoimmune Disease. This event is FREE for ASGCT members.


With seven CAR T cell therapies currently approved in the United States to treat certain forms of cancer, researchers and clinicians are exploring other applications to treat autoimmune diseases. Following the ground-breaking first report of a patient with severe systemic lupus erythematosus who was successfully treated with CD19 CAR T cells, clinical trials of CAR T cell therapies for lupus nephritis, scleroderma, myositis, and multiple sclerosis have taken flight across the world.


Moderator

Boris Fehse, PhDUniversity Medical Centre Hamburg-Eppendorf


Sekretariat der DG-GT e.V.
Institut für Experimentelle Hämatologie
Hildegard Büning
Carl-Neuberg-Str. 1
30625 Hannover

  • Facebook
  • LinkedIn
  • YouTube

© 2021 Die Deutsche Gesellschaft für Gentherapie e.V.

bottom of page